Before experiencing wounds or diabetic ulcers, patients affected by diabetic peripheral neuropathy suffer from loss of sensation, loss of balance, chronic pain, or loss of feeling in their extremities. An infrared therapy is showing promising results for the reduction of pain from peripheral neuropathy.

Anodyne Infrared Therapy is a treatment that uses light energy to exponentially increase (up to 400%) the circulation in peripheral areas (arms, legs). Light-emitting diodes are fitted into flexible pads that can be applied directly to the skin on any affected part of the body. The light energy helps increase blood flow by delivering nutrients to the injured site. Anodyne therapy consists of 10 to 12 sessions lasting 30 minutes each. During this time, energy is penetrating your tissues increasing circulation that results in reducing pain and rapid wound healing.

Light energy helps your body release a gas called Nitric Oxide from your own red blood cells. This powerful molecule plays a critical role in the health of your arteries. Anodyne Infrared Therapy can be used to intervene at the early stages of the disease in order to prevent the more serious complications. If you suffer from any condition distinguished by pain and inflammation or a condition characterized by poor circulation, Anodyne may be a painless, non - invasive treatment option for you.

The benefits of Anodyne Therapy extend as far-reaching as: arthritis, bursitis, tendonitis, carpal tunnel syndrome, sprains, temporal mandibular joint disorders ("TMJ"), slow healing wounds, and stress fractures. Let the light shed some promising results on your painful ailments. I'm curious to see how well it works. I called a local office and setup an appointment. If it works for me - you'll be the first to read about it. Stay tuned...

The hemoglobin A1c has been regarded as the undisputed champion for measurement of glycemic control...until now. Those of us running from diabetic complications understand the necessity of this test. Waiting 3 months (or more) gives these glycated red blood cells a lot of time to play havoc with our small blood vessels, over time resulting in a quagmire of diabetic complications. Glycation is the cause of the long-term complications of diabetes. There is a gap between the data provided by daily blood glucose testing and the information on the long-term health of the diabetic patient supplied by the HbA1c test.

Epinex Diagnostics developed the G1A to measure the albumin in the blood, not the hemoglobin. The albumin lifespan is much shorter than the hemoglobin. Albumin regenerates every 2 to 3 weeks, whereas hemoglobin takes 120 days. Albumin is a serum protein in the blood that can be measured more precisely, more frequently, resulting in more effective diabetes management. The G1A test requires a drop of blood, as opposed to the full laboratory tube needed for the A1c test. The G1A test takes 5 minutes, whereas the A1c results could take weeks. In contrast to daily blood glucose and semi-annual A1c testing, the G1A glycated albumin index offers amore accurate predictor of glycation by testing once a month, instead of testing the A1c every 3 or 6 months.

I'm not sure about you, but if someone said they know of a way to manage my diabetes that is more effective, less time consuming, and allows for earlier therapeutic intervention-- sign me up! The G1A has the potential to become the new industry standard for diabetes management. Ask your doctor if he or she has heard of it yet. If they dismiss the idea-- ask them how important accuracy is in diabetes management. There's your answer.